PMID: 6987932Apr 1, 1980Paper

Post-transfusion hepatitis: current perspectives

Annals of Internal Medicine
R D Aach, R A Kahn

Abstract

Viral hepatitis is still the most serious post-transfusion complication. Despite the routine screening of donor blood for the hepatitis type B surface antigen in the United States, post-transfusion hepatitis develops in approximately 7% of blood recipients. Type B hepatitis accounts for only 10% to 15% of cases; non-A, non-B hepatitis constitutes the remainder. Non-A, non-B hepatitis is usually asymptomatic and anicteric but often runs a prolonged course manifested by persistent or intermittent elevations of alanine aminotransferase levels. The risk of developing non-A, non-B hepatitis is increased considerably when blood from paid rather than volunteer donors is transfused. Although there are currently no definitive preventive measures that can be used to reduce the attack rate, the possibility of developing a serologic test fot the non-A, non-B agent is under active investigation.

Citations

Jun 1, 1988·European Journal of Epidemiology·A BiglinoP Gioannini
Oct 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·E T Crosby
Apr 15, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Hiroomi MurayamaAkemi Kawamura
Mar 1, 1995·The Annals of Thoracic Surgery·L SandrelliO Alfieri
Jan 1, 1987·Transactions of the Royal Society of Tropical Medicine and Hygiene·O A Shobokshi, F E Serebour
Mar 12, 1999·Lancet·J Cash, K Boyd
Mar 10, 2001·Transfusion·R G Strauss
Mar 10, 2001·Transfusion·A M SanchezUNKNOWN Retrovirus Epidemiology Donor Study
Jun 6, 1985·The New England Journal of Medicine·F RosinaM Rizzetto
Jul 1, 1989·Journal of Gastroenterology and Hepatology·L M HuangD S Chen
Jan 17, 1987·British Medical Journal·L A Kay
Nov 26, 1988·BMJ : British Medical Journal·G N RussellM A Fox
Nov 1, 1990·Journal of Clinical Pathology·D J Goldie, A A McConnell
Jun 1, 1990·Postgraduate Medical Journal·M SonnenblickR Tur-Kaspa
Jun 16, 2004·Critical Care : the Official Journal of the Critical Care Forum·E Patchen Dellinger, Daniel A Anaya
Jan 1, 1989·Blut·H W Reesink, C L van der Poel
Jun 1, 1986·European Journal of Epidemiology·C GalloG Giusti
Feb 1, 1987·World Journal of Surgery·P RebullaG Sirchia
Jun 1, 1985·The American Journal of the Medical Sciences·J Shorey
Jun 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·N Shusterman, I Singer
Nov 1, 1985·Kidney International·M R WeirN L Tilney
Oct 1, 1989·The Annals of Thoracic Surgery·R PageT Williets
Sep 1, 1983·The American Journal of Medicine·J C WadeJ H Hoofnagle
Nov 1, 1981·The Journal of Surgical Research·D Rose, T Coutsoftides
Jun 1, 1986·Disease-a-month : DM·L S Friedman, J L Dienstag
Jan 1, 1983·Vox Sanguinis·J M HernándezJ Triginer
Nov 1, 1983·The Journal of Pediatrics·F AlvarezD Alagille
May 1, 1991·Journal of Hepatology·S V FeinmanR Herst
Apr 1, 1989·The Annals of Thoracic Surgery·L W BrittonT M Older
Mar 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M HoyosJ Berenguer
Mar 1, 1989·Journal of Gastroenterology and Hepatology·J B DilawariB N Walia
Jan 1, 1987·Scandinavian Journal of Thoracic and Cardiovascular Surgery·J O SolemC Olin
Jul 1, 1990·The Korean Journal of Internal Medicine·S K HaS H Chung
May 1, 1983·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H M LiebermanD A Shafritz
Sep 25, 1982·British Medical Journal·P M Jones
Jul 1, 1988·Revista Da Sociedade Brasileira De Medicina Tropical·C TakahashiF Ruzany
Jan 1, 1989·Scandinavian Journal of Infectious Diseases. Supplementum·L Mattsson
Sep 25, 1982·British Medical Journal·P J Scheuer
Sep 14, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Adam C WintersThomas D Schiano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.